1. Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India
   Varsha Singh et al, 2019, Current Problems in Cancer CrossRef
2. Molecular Spectrum of Somatic EGFR and KRAS Gene Mutations in non Small Cell Lung Carcinoma: Determination of Frequency, Distribution Pattern and Identification of Novel Variations in Indian Patients
   Bibhu Ranjan Das et al, 2015, Pathology & Oncology Research CrossRef
3. KRAS et adénocarcinome bronchique. Entre déceptions et espoirs
   N. Guibert et al, 2016, Revue des Maladies Respiratoires CrossRef
4. Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study
   Xue-Ning Yang et al, 2022, JTO Clinical and Research Reports CrossRef
5. Impact of the Bim Deletion Polymorphism on Survival Among Patients With Completely Resected Non–Small-Cell Lung Carcinoma
   Jun Atsumi et al, 2016, Journal of Global Oncology CrossRef
6. High nuclear expression of proteasome activator complex subunit 1 predicts poor survival in soft tissue leiomyosarcomas
   Sha Lou et al, 2016, Clinical Sarcoma Research CrossRef
7. Current therapy of KRAS-mutant lung cancer
   Aron Ghimessy et al, 2020, Cancer and Metastasis Reviews CrossRef
8. Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer
   Yoichi Ohtaki et al, 2016, Surgery Today CrossRef
9. Molecular biomarkers for lung adenocarcinoma
   Olivier Calvayrac et al, 2017, European Respiratory Journal CrossRef
10. Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma
    Xiuzhi Zhou et al, 2018, Oncology Letters CrossRef
11. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target
    Tatiana Correa Carneiro-Lobo et al, 2019, Lung Cancer CrossRef
12. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
    Edmilson Ozorio dos Santos et al, 2016, Molecular Cancer CrossRef
13. Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery
    Junghee Lee et al, 2023, Annals of Surgery CrossRef
14. An experimental guideline for the analysis of histologically heterogeneous tumors by MALDI-TOF mass spectrometry imaging
    Sha Lou et al, 2017, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef